search
Back to results

Closed-Loop Insulin Delivery in Children Less Than 7 Years of Age

Primary Purpose

Type 1 Diabetes Mellitus

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Closed-loop Insulin Pump therapy
Standard Insulin Pump Therapy
Sponsored by
Boston Children's Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Type 1 Diabetes Mellitus focused on measuring Closed Loop Insulin Delivery, Diabetes, Type 1 Diabetes, Artificial pancreas

Eligibility Criteria

6 Months - 7 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age < 7 years old
  • Type 1 Diabetes (as diagnosed by outpatient endocrinologist) with duration greater than 6 months
  • Treated with insulin pump therapy for greater than 6 weeks

Exclusion Criteria:

  • Any other chronic medical condition
  • Weight below 10 kg as this is the minimal required weight for the amount of blood being drawn

Sites / Locations

  • Children's Hospital Boston

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Standard Insulin Pump Therapy first, then Closed Loop

Closed Loop first, then Standard Insulin Pump Therapy

Arm Description

Standard therapy day 1, Closed-Loop therapy day 2.

Closed-loop therapy day 1, standard therapy day 2.

Outcomes

Primary Outcome Measures

Nocturnal Glycemic Control
Time spent within target glucose range based on the glucose meter measurements between 10 PM and 8 AM. The target range is 110-200 mg/dl as this is the American Diabetes Association defined target overnight range for this age group.

Secondary Outcome Measures

Post-prandial Glycemic Control
Peak post-prandial blood sugar between 8 AM and noon
Number of Interventions for Hypoglycemia
The number of interventions for hypoglycemia between 10 PM - 8 AM.
Pre-lunch Blood Glucose Level
Blood glucose levels were documented at 12 pm just prior to being served lunch.

Full Information

First Posted
August 19, 2011
Last Updated
August 7, 2018
Sponsor
Boston Children's Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT01421225
Brief Title
Closed-Loop Insulin Delivery in Children Less Than 7 Years of Age
Official Title
Closed-Loop Insulin Delivery in Children Less Than 7 Years of Age
Study Type
Interventional

2. Study Status

Record Verification Date
August 2018
Overall Recruitment Status
Completed
Study Start Date
August 2011 (undefined)
Primary Completion Date
August 15, 2013 (Actual)
Study Completion Date
August 15, 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Boston Children's Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The investigators are conducting this study to find out whether a new device can control blood sugar levels in children who have Type 1 diabetes. In Type 1 diabetes, children have high blood sugar levels because they do not make enough insulin. The standard treatment is to give insulin either by shots or using an insulin pump. A new device, called closed-loop insulin therapy, uses a continuous glucose monitor (CGMs) linked to an insulin pump by a computer. The CGM will send the sugar levels to a computer which automatically figures out how much insulin to give and then gives that amount of insulin through the insulin pump. It will give the child insulin to bring sugar levels down if they are high, and will give less insulin if the child's blood sugar is getting lower. Earlier research using closed-loop insulin therapy has shown the ability for it to improve diabetes care in adults and older children, but there has been no research of closed-loop insulin therapy in young children. This study will compare children's current insulin therapy with the closed-loop system. The knowledge that the investigators gain from this research will help us to figure out whether closed-loop therapy can work in young children, hopefully leading to better Type 1 diabetes care.
Detailed Description
We will perform a randomized cross-over study of semi-closed-loop insulin therapy in children less than 7 years old with type 1 diabetes. Subjects will be admitted to the inpatient clinical research center for 48 hours. They will receive their standard home insulin therapy for one day and semi-closed-loop insulin therapy for the other day.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Type 1 Diabetes Mellitus
Keywords
Closed Loop Insulin Delivery, Diabetes, Type 1 Diabetes, Artificial pancreas

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
10 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Standard Insulin Pump Therapy first, then Closed Loop
Arm Type
Active Comparator
Arm Description
Standard therapy day 1, Closed-Loop therapy day 2.
Arm Title
Closed Loop first, then Standard Insulin Pump Therapy
Arm Type
Active Comparator
Arm Description
Closed-loop therapy day 1, standard therapy day 2.
Intervention Type
Device
Intervention Name(s)
Closed-loop Insulin Pump therapy
Other Intervention Name(s)
Continuous glucose monitor and computer-linked insulin pump
Intervention Description
Subjects insulin doses were adjusted based on a proportional-integral-derivative algorithm using the continuous glucose monitor readings from 10 PM - noon.
Intervention Type
Device
Intervention Name(s)
Standard Insulin Pump Therapy
Other Intervention Name(s)
Open-Loop Therapy
Intervention Description
Subjects insulin doses followed their usual home routine.
Primary Outcome Measure Information:
Title
Nocturnal Glycemic Control
Description
Time spent within target glucose range based on the glucose meter measurements between 10 PM and 8 AM. The target range is 110-200 mg/dl as this is the American Diabetes Association defined target overnight range for this age group.
Time Frame
Participants will be followed for the duration of the 48 hour protocol.
Secondary Outcome Measure Information:
Title
Post-prandial Glycemic Control
Description
Peak post-prandial blood sugar between 8 AM and noon
Time Frame
Participants will be followed for the duration of the 48 hour protocol
Title
Number of Interventions for Hypoglycemia
Description
The number of interventions for hypoglycemia between 10 PM - 8 AM.
Time Frame
Participants will be followed for the duration of the 48 hour protocol
Title
Pre-lunch Blood Glucose Level
Description
Blood glucose levels were documented at 12 pm just prior to being served lunch.
Time Frame
Participants will be followed for the duration of the 48 hour protocol

10. Eligibility

Sex
All
Minimum Age & Unit of Time
6 Months
Maximum Age & Unit of Time
7 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age < 7 years old Type 1 Diabetes (as diagnosed by outpatient endocrinologist) with duration greater than 6 months Treated with insulin pump therapy for greater than 6 weeks Exclusion Criteria: Any other chronic medical condition Weight below 10 kg as this is the minimal required weight for the amount of blood being drawn
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Andrew Dauber, MD
Organizational Affiliation
Boston Children's Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Children's Hospital Boston
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02115
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
23033237
Citation
Dauber A, Corcia L, Safer J, Agus MS, Einis S, Steil GM. Closed-loop insulin therapy improves glycemic control in children aged <7 years: a randomized controlled trial. Diabetes Care. 2013 Feb;36(2):222-7. doi: 10.2337/dc12-1079. Epub 2012 Oct 1.
Results Reference
result

Learn more about this trial

Closed-Loop Insulin Delivery in Children Less Than 7 Years of Age

We'll reach out to this number within 24 hrs